Search by Drug Name or NDC
NDC 55111-0131-45 Ranitidine 75 mg/1 Details
Ranitidine 75 mg/1
Ranitidine is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Dr. Reddy's Laboratories Limited. The primary component is RANITIDINE HYDROCHLORIDE.
Product Information
NDC | 55111-0131 |
---|---|
Product ID | 55111-131_654a9ddb-f441-a17a-f8ae-633148d041c8 |
Associated GPIs | 49200020100303 |
GCN Sequence Number | 023441 |
GCN Sequence Number Description | ranitidine HCl TABLET 75 MG ORAL |
HIC3 | Z2D |
HIC3 Description | HISTAMINE H2-RECEPTOR INHIBITORS |
GCN | 10202 |
HICL Sequence Number | 004520 |
HICL Sequence Number Description | RANITIDINE HCL |
Brand/Generic | Generic |
Proprietary Name | Ranitidine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Ranitidine |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 75 |
Active Ingredient Units | mg/1 |
Substance Name | RANITIDINE HYDROCHLORIDE |
Labeler Name | Dr. Reddy's Laboratories Limited |
Pharmaceutical Class | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA075294 |
Listing Certified Through | 2024-12-31 |
Package
Package Images


NDC 55111-0131-45 (55111013145)
NDC Package Code | 55111-131-45 |
---|---|
Billing NDC | 55111013145 |
Package | 1 BOTTLE in 1 CARTON (55111-131-45) / 45 TABLET in 1 BOTTLE |
Marketing Start Date | 2000-03-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 12a38e29-130c-6d41-1753-acccb0b41efe Details
Uses
Warnings
Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers
Do not use
- if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.
These may be signs of a serious condition. See your doctor. - with other acid reducers
Ask a doctor before use if you have
- had heartburn over 3 months. This may be a sign of a more serious condition.
- heartburn with lightheadedness, sweating or dizziness
- chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
- frequent chest pain
- frequent wheezing, particularly with heartburn
- unexplained weight loss
- nausea or vomiting
- stomach pain
- kidney disease
Ask a doctor or pharmacist before use if you are
• taking a prescription drug. Acid reducers may interact with certain prescription drugs.
Directions
- adults and children 12 years and over:
- to relieve symptoms, swallow 1 tablet with a glass of water
- to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
- can be used up to twice daily (do not take more than 2 tablets in 24 hours)
- do not chew tablet
- children under 12 years: ask a doctor
Other information
Inactive ingredients
SPL UNCLASSIFIED SECTION
INGREDIENTS AND APPEARANCE
RANITIDINE
ranitidine tablet |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Labeler - Dr. Reddy's Laboratories Limited (650562841) |
Revised: 5/2019
Document Id: 654a9ddb-f441-a17a-f8ae-633148d041c8
Set id: 12a38e29-130c-6d41-1753-acccb0b41efe
Version: 10
Effective Time: 20190502